{"title":"101 studies flagged as bogus COVID cure pusher sees career unravel","link":"https://arstechnica.com/?p=2014943","date":1712250302000,"content":"<div>\n<figure>\n  <img src=\"https://cdn.arstechnica.net/wp-content/uploads/2024/04/GettyImages-1240105742-800x533.jpeg\" alt=\"Microbiologist Didier Raoult addresses a press conference on COVID-19 at the IHU medical institute in Marseille on April 20, 2022.\" />\n      <p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2024/04/GettyImages-1240105742.jpeg\">Enlarge</a> <span>/</span> Microbiologist Didier Raoult addresses a press conference on COVID-19 at the IHU medical institute in Marseille on April 20, 2022. (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/virologist-didier-raoult-addresses-a-press-conference-on-news-photo/1240105742?adppopup=true\">Getty | </a>)</p>  </figure>\n\n\n\n\n\n\n<div><a name=\"page-1\"></a></div>\n<p>A scientific journal published by Elsevier has reportedly posted a stunning 101 expressions of concern on studies connected to Didier Raoult, a disgraced French microbiologist who gained international prominence amid the pandemic by promoting, with little evidence, that the malaria drug hydroxychloroquine could treat COVID-19â€”<a href=\"https://www.cochrane.org/news/chloroquine-or-hydroxychloroquine-useful-treating-people-covid-19-or-preventing-infection\">a claim</a> that has now been firmly <a href=\"https://arstechnica.com/science/2020/06/who-gives-up-on-hydroxychloroquine-for-covid-19-stops-trials/\">debunked</a>.</p>\n<p><a href=\"https://retractionwatch.com/2024/04/03/embattled-researcher-didier-raoult-earns-dozens-more-expressions-of-concern-and-another-retraction/\">According to Retraction Watch</a>, the journal New Microbes and New Infections posted 101 expressions of concern on Raoult's works recently, including <a href=\"https://www.sciencedirect.com/science/article/pii/S2052297523001075\">a 2023 study that drew sharp criticism.</a> The study involved giving hydroxychloroquine to tens of thousands of COVID-19 patients after data indicated that it wasn't effective and the French government rescinded permission for its use against COVID-19. An op-ed in the major French newspaper Le Monde described the study as \"<a href=\"https://www.lemonde.fr/sciences/article/2023/05/28/recherche-clinique-a-l-ihu-de-marseille-en-l-absence-de-reaction-des-institutions-les-graves-manquements-constates-pourraient-devenir-la-norme_6175184_1650684.html\">the largest 'wild' therapeutic trial known to date</a>.\"</p>\n<p>The expressions of concern also come as Raoult saw his tenth study retracted, Retraction Watch noted.</p></div><p><a href=\"https://arstechnica.com/?p=2014943#p3\">Read 7 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=2014943&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"7a6fe19e7540c00ef85485bb69120600b29d205d3a3f13c37669762d0b20ecf8","category":"Tech"}